Restructuring Actions (Tables)

9 Months Ended

Sep. 30, 2022

Restructuring and Related Activities [Abstract]

Schedule of restructuring and related costs

The related restructuring charges for periods presented were recorded in the income statement as follows:

	Nine months ended September 30,
(Millions)	2022		2021
Cost of sales	$	—	$	18
Selling, general and administrative expenses	12		74
Research, development and related expenses	6		15
Total operating income impact	$	18	$	107

The business segment operating income impact of these restructuring charges is summarized as follows:

	Nine months ended September 30,
	Employee-Related
(Millions)	2022		2021
Safety and Industrial	$	2	$	28
Transportation and Electronics	4		23
Health Care	2		18
Consumer	2		6
Corporate and Unallocated	8		32
Total Operating Expense	$	18	$	107

The divestiture-related restructuring actions were recorded in the income statement as follows:

(Millions)	Third Quarter 2022
Cost of sales	$	3
Selling, general and administrative expenses	36
Research, development and related expenses	2
Total operating income impact	$	41

Schedule of restructuring reserve by type of cost

Restructuring actions, including cash and non-cash impacts, follow:

(Millions)	Employee-Related
Accrued restructuring action balance as of December 31, 2021	$	87
Incremental expense incurred in the first quarter of 2022	18
Cash payments	(84)
Adjustments	(9)
Accrued restructuring action balances as of June 30, 2022	$	12

Divestiture-related restructuring actions, including cash impacts, follow:

(Millions)	Employee-Related
Expense incurred in the third quarter of 2022	41
Cash payments	(3)
Accrued restructuring action balances as of September 30, 2022	$	38